Jan-Quinten Mol

Jan-Quinten Mol

Auto-generated profile, based on publicly available information

Jan-Quinten Mol

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands (L.H., T.J.L., J.L.v.d.Z., J.-Q.M., R.G.A.v.d.W., J.T., N.v.R., R.H.J.A.V.).

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2025 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Open access
RVRick Volleberg
Rick Volleberg
ARAndi Rroku
Andi Rroku
JMJan-Quinten Mol
Jan-Quinten Mol
RHRenicus S. Hermanides
Renicus S. Hermanides
MLMaarten van Leeuwen
Maarten van Leeuwen
NRNiels van Royen
Niels van Royen
BACKGROUND: Despite fractional flow reserve (FFR)–guided deferral of revascularization, recurrent events in patients with diabetes or after myocardial infarction remain common. This study aimed to assess the association between FFR-negative but high-risk nonculprit lesions and clinical outcomes. METHODS: This is a patient-level pooled analysis of the prospective natural-history COMBINE (OCT-FFR) study (Optical Coherence Tomography Morphologic and Fractional Flow Reserve Assessment in Diabetes Mellitus Patients) and PECTUS-obs study (Identification of Risk Factors for Acute Coronary Events by OCT After STEMI and NSTEMI Patients With Residual Non- Flow Limiting Lesions). Optical coherence tomography was performed on all FFR-negative (FFR >0.80) native nonculprit lesions. Patients or lesions with a high-risk plaque were compared with those without a high-risk plaque. A high-risk plaque was defined in the presence of at least 2 prespecified criteria: (1) lipid arc ≥90 o , (2) minimum fibrous cap thickness <65 µm, and (3) presence of either plaque rupture or thrombus. The primary end points were native major adverse cardiovascular events (composite of all-cause mortality, nonfatal myocardial infarction, or unplanned revascularization excluding stent-failure–related events and nonattributable events) and target lesion failure (composite of cardiac death, target vessel myocardial infarction, or target lesion revascularization). RESULTS: Among 810 patients, 450 (55.6%) had a history of diabetes and 482 (59.5%) presented with myocardial infarction. At least 1 high-risk plaque was identified in 271 (33.5%) patients and 287 (30.6%) lesions. Over a median follow-up of 761 (interquartile range, 731–1175) days, the presence of a high-risk plaque was associated with patient-level native major adverse cardiovascular events (hazard ratio, 2.127 [95% CI, 1.451–3.120]; P <0.001) and lesion-level target lesion failure (hazard ratio, 2.623 [95% CI, 1.559–4.414]; P <0.001). The risk of adverse outcomes increased with the copresence of multiple high-risk features. CONCLUSIONS: FFR-negative but high-risk nonculprit lesions are associated with adverse patient- and lesion-level clinical outcomes. These findings emphasize the additional value of intracoronary imaging in patients with FFR-negative nonculprit lesions. REGISTRATION: URL: https://clinicaltrials.gov ; Unique identifier: NCT02989740; Unique identifier: NCT03857971.

1 February 2023 in Trends in Cardiovascular Medicine
Verified
Journal Article
Open access
RVRick Volleberg
Rick Volleberg
JMJan-Quinten Mol
Jan-Quinten Mol
DHDirk van der Heijden
Dirk van der Heijden
MMMartijn Meuwissen
Martijn Meuwissen
MLMaarten van Leeuwen
Maarten van Leeuwen
NRNiels Van Royen
Niels Van Royen
Angiography alone is the most commonly used imaging modality for guidance of percutaneous coronary interventions. Angiography is limited, however, by several factors, including that it only portrays a low resolution, two-dimensional outline of the lumen and does not inform on plaque composition and functional stenosis severity. Optical coherence tomography (OCT) is an intracoronary imaging technique that has superior spatial resolution compared to all other imaging modalities. High-resolution imaging of the vascular wall enables precise measurement of vessel wall and luminal dimensions, more accurately informing about the anatomic severity of epicardial stenoses, and also provides input for computational models to assess functional severity. The very high-resolution images also permit plaque characterization that may be informative for prognostication. Moreover, periprocedural imaging provides valuable information to guide lesion preparation, stent implantation and to evaluate acute stent complications for which iterative treatment might reduce the occurrence of major adverse stent events. As such, OCT represent a potential future all-in-one tool that provides the data necessary to establish the indications, procedural planning and optimization, and final evaluation of percutaneous coronary revascularization.

7 July 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
JMJan-Quinten Mol
Jan-Quinten Mol
ABAnouar Belkacemi
Anouar Belkacemi
RVRick Hja Volleberg
Rick Hja Volleberg
MMMartijn Meuwissen
Martijn Meuwissen
APAlexey V Protopopov
Alexey V Protopopov
NRNiels Van Royen
Niels Van Royen
Introduction In patients with myocardial infarction, the decision to treat a nonculprit lesion is generally based on its physiological significance. However, deferral of revascularisation based on nonischaemic fractional flow reserve (FFR) values in these patients results in less favourable outcomes compared with patients with stable coronary artery disease, potentially caused by vulnerable nonculprit lesions. Intravascular optical coherence tomography (OCT) imaging allows for in vivo morphological assessment of plaque ‘vulnerability’ and might aid in the detection of FFR-negative lesions at high risk for recurrent events. Methods and analysis The PECTUS-obs study is an international multicentre prospective observational study that aims to relate OCT-derived vulnerable plaque characteristics of nonflow limiting, nonculprit lesions to clinical outcome in patients with myocardial infarction. A total of 438 patients presenting with myocardial infarction (ST-elevation myocardial infarction and non-ST-elevation myocardial infarction) will undergo OCT-imaging of any FFR-negative nonculprit lesion for detection of plaque vulnerability. The primary study endpoint is a composite of major adverse cardiovascular events (all-cause mortality, nonfatal myocardial infarction or unplanned revascularisation) at 2-year follow-up. Secondary endpoints will be the same composite at 1-year and 5-year follow-up, target vessel failure, target vessel revascularisation, target lesion failure and target lesion revascularisation. Ethics and dissemination This study has been approved by the Medical Ethics Committee of the region Arnhem-Nijmegen. The results of this study will be disseminated in a main paper and additional papers with subgroup analyses. Trial registration number NCT03857971.

1 September 2025 in European Heart Journal
Verified
Journal Article
Open access
RVRick Volleberg
Rick Volleberg
TLThijs J Luttikholt
Thijs J Luttikholt
RWRuben van der Waerden
Ruben van der Waerden
PCPierandrea Cancian
Pierandrea Cancian
JZJoske van der Zande
Joske van der Zande
NRNiels Van Royen
Niels Van Royen
Background and Aims: Coronary thin-cap fibroatheromas (TCFA) are associated with adverse outcome, but identification of TCFA requires expertise and is highly time-demanding. This study evaluated the utility of artificial intelligence (AI) for TCFA identification in relation to clinical outcome. Methods: The PECTUS-AI study is a secondary analysis from the prospective observational PECTUS-obs study, in which 438 patients with myocardial infarction underwent optical coherence tomography (OCT) of all fractional flow reserve-negative non-culprit lesions (i.e. target lesions). OCT images were analyzed for the presence of TCFA by an independent core laboratory (CL-TCFA) and OCT-AID, a recently developed and validated AI segmentation algorithm (AI-TCFA). The primary outcome was defined as the composite of death from any cause, non-fatal myocardial infarction or unplanned revascularisation at 2 years (±30 days), excluding procedural and stent-related events. Results: Among 414 patients, AI-TCFA and CL-TCFA were identified in 143 (34.5%) and 124 (30.0%) patients, respectively. AI-TCFA within the target lesion was significantly associated with the primary outcome [hazard ratio (HR) 1.99, 95% confidence interval (CI) 1.02–3.90, P = .04], while the HR for CL-TCFA was non-significant (1.67, 95% CI: .84–3.30, P = .14). When evaluating the complete pullback, AI-TCFA showed an even stronger association with the primary outcome (HR 5.50, 95% CI: 1.94–15.62, P < .001; negative predictive value 97.6%, 95% CI: 94.0%–99.3%). Conclusions: AI-based OCT image analysis allows standardized identification of patients at increased risk of adverse cardiovascular outcome, offering an alternative to manual image analysis. Furthermore, AI-assisted evaluation of complete imaged segments results in better prognostic discrimatory value than evaluation of the target lesion only.

3 December 2020 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
PDF file
JMJan-Quinten Mol
Jan-Quinten Mol
MBMichiel J. Bom
Michiel J. Bom
PDPeter Damman
Peter Damman
PKPaul Knaapen
Paul Knaapen
NRNiels Van Royen
Niels Van Royen
Objectives. To assess the safety and efficacy of pre-emptive treatment of optical coherence tomography- (OCT-) derived vulnerable, non-flow-limiting, non-culprit lesions in patients with myocardial infarction (MI). Background. Intracoronary imaging with OCT can aid in the decision to treat non-flow-limiting lesions by identifying vulnerable plaques. Pre-emptive treatment of these lesions might improve patient outcome by sealing these plaques. Bioresorbable vascular scaffolds (BVS) have theoretical benefit for this treatment because they dissolve completely over time. Methods. In patients presenting with MI, non-culprit lesions with a fractional flow reserve 0.8 were imaged with OCT. Vulnerable plaques were randomised to either percutaneous coronary intervention (PCI) with bioresorbable vascular scaffold (BVS) placement or optimal medicinal therapy (OMT). The primary outcome was a composite of all-cause mortality, non-fatal MI, and unplanned revascularisation at 1-year follow-up. Results. The trial was stopped prematurely after retraction from the market of the Absorb BVS. At that time, a total of 34 patients were randomised. At two years, the composite endpoint occurred 3 times (18.8) in the BVS group and 1 time (6.3) in the OMT group. Apart from one elective PCI for stable angina in the OMT group, no target lesions in any group were revascularised. Conclusions. Pre-emptive stenting of vulnerable plaques had no evident benefit compared to conservative treatment. However, due to the low number of included patients, no definite conclusions could be drawn. Identifying and potentially treating vulnerable plaques remains an important target for future research. This trial is registered under https://www.trialregister.nl/trial/NL4177 on 08-12-2015.

15 March 2025 in European Heart Journal - Digital Health
Verified
Journal Article
Open access
RVRick Volleberg
Rick Volleberg
RWRuben van der Waerden
Ruben van der Waerden
TLThijs J Luttikholt
Thijs J Luttikholt
JZJoske van der Zande
Joske van der Zande
PCPierandrea Cancian
Pierandrea Cancian
NRNiels Van Royen
Niels Van Royen
Aims: Intracoronary optical coherence tomography (OCT) provides detailed information on coronary lesions, but interpretation of OCT images is time-consuming and subject to interobserver variability. The aim of this study was to develop and validate a deep learning-based multiclass semantic segmentation algorithm for OCT (OCT-AID). Methods and results: A reference standard was obtained through manual multiclass annotation (guidewire artefact, lumen, side branch, intima, media, lipid plaque, calcified plaque, thrombus, plaque rupture, and background) of OCT images from a representative subset of pullbacks from the PECTUS-obs study. Pullbacks were randomly divided into a training and internal test set. An additional independent dataset was used for external testing. In total, 2808 frames were used for training and 218 for internal testing. The external test set comprised 392 frames. On the internal test set, the mean Dice score across nine classes was 0.659 overall and 0.757 on the true-positive frames, ranging from 0.281 to 0.989 per class. Substantial to almost perfect agreement was achieved for frame-wise identification of both lipid (κ=0.817, 95% CI 0.743–0.891) and calcified plaques (κ=0.795, 95% CI 0.703–0.887). For plaque quantification (e.g. lipid arc, calcium thickness), intraclass correlations of 0.664–0.884 were achieved. In the external test set, κ-values for lipid and calcified plaques were 0.720 (95% CI 0.640–0.800) and 0.851 (95% CI 0.794–0.908), respectively. Conclusion: The developed multiclass semantic segmentation method for intracoronary OCT images demonstrated promising capabilities for various classes, while having included difficult frames, such as those containing artefacts or destabilized plaques. This algorithm is an important step towards comprehensive and standardized OCT image interpretation.